If you have any question, please feel free to email us. We will touch with you as soon as possible.
Bosutinib belongs to a family of medications called protein tyrosine kinase inhibitors. It is used to treat adults with certain types of Philadelphia-positive chronic myelogenous leukemia (Ph+ CML) in blast crisis (sudden attack), accelerated phase (fast growth), or in chronic phase (long-term illness). For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Bosutinib Monohydrate Tablets |
| Trade name | Bosulif |
| Specification | 100mg |
| Main ingredients | Bosutinib Monohydrate |
| Dosage Form | Tablet |
| MA Holder | Pfizer Europe MA EEIG |
| Category | Reference Listed Drugs (RLDs) |
Indications:
Bosulif is indicated for the treatment of adult patients with:
1. newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).
2. CP, accelerated phase (AP), and blast phase (BP) Ph+ CML previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: bosutinib monohydrate tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Agomelatine Tablets, Adefovir Dipivoxil Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Olanzapine Tablets, Argatroban Injection, Phenytoin Sodium Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
